Bayer Plans Mfg Investment in IndonesiaBy
PT Bayer Indonesia has inaugurated a new warehouse at its healthcare manufacturing plant in Cimanggis, Depok, West Java, Indonesia. The expansion is part of an ongoing EUR 8.1 million ($8.8 million) investment that aims to increase the overall manufacturing capability of the facility, thus enabling it to export global healthcare brand products to more than 20 countries in 2015 and additional countries in subsequent years.
The Bayer HealthCare factory in Cimanggis uses both effervescent and non-effervescent production technologies to manufacture over-the-counter pharmaceutical and multivitamin products. As part of the ongoing investment, another production line for pharmaceutical effervescent products is being constructed to increase production volume. In the near future, Bayer plans to increase its production capacity at the Cimanggis plant.
As part of the overall expansion plan, Bayer is planning to add production facility for manufacturing prescription drugs at the Cimanggis plant. Starting in 2015, Bayer plans to invest an additional EUR 8.1 million ($8.8 million) in the Cimanggis plant, which will enable the plant to start manufacturing pharmaceutical products, on top of the consumer care products that the plant is currently is producing.
Bayer's ongoing investment in their Cimanggis manufacturing facility aligns with the Indonesian Ministry of Industry's efforts in strengthening the industrial sector in Indonesia in 2015. Based on data from the ministry, industrial sectors with increasing growth in this year's first quarter are chemical, pharmaceutical, and traditional medicine sectors,, which increased 9% year.